{
    "clinical_study": {
        "@rank": "139558", 
        "acronym": "ANOPEC3", 
        "arm_group": {
            "arm_group_label": "Aortic aneurysm", 
            "description": "Patients with aortic aneurysm >30mm and < 50mm"
        }, 
        "brief_summary": {
            "textblock": "We aimed to see if aortic aneurysms could be followed-up by circulating endothelial\n      progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood level."
        }, 
        "brief_title": "Circulating Endothelial Progenitor Cells and Aortic Aneurysm", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "- Aortic Aneurysm", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm"
            ]
        }, 
        "detailed_description": {
            "textblock": "Circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- have been\n      shown to be inversely correlated to aortic aneurysm size. We aimed to see if aortic\n      aneurysms could be followed-up by circulating endothelial progenitor cells CD34+144+CD14-\n      and CD34+VEGF-R2+CD14- blood level. 40 patients followed for known aortic aneurysm >30mm and\n      <50mm will be followed up every 6 months during 2 years. Each 6 months they will have a\n      consultation by their physiologist with an echo or a CT-scan. At the same time, a 10ML blood\n      sample will be taken to assess the circulating endothelial progenitor cells CD34+144+CD14-\n      and CD34+VEGF-R2+CD14- blood level."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aortic aneurysm size >30mm and > 50mm\n\n        Exclusion Criteria:\n\n          -  Infectious disease\n\n          -  Inflammatory disease\n\n          -  Liver insuffisency\n\n          -  Cancer evolutive\n\n          -  Pregnant women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with aortic aneurysm"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918982", 
            "org_study_id": "147/362"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Aortic aneurysm", 
            "circulating endothelial progenitor cells"
        ], 
        "lastchanged_date": "August 7, 2013", 
        "number_of_groups": "1", 
        "official_title": "Interest of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in the Follow-up of Aortic Aneurysm", 
        "overall_contact": {
            "email": "sidney.chocron@univ-fcomte.fr", 
            "last_name": "Sidney Chocron", 
            "phone": "+33381533121"
        }, 
        "overall_official": [
            {
                "affiliation": "Universit\u00e9 de Franche-comt\u00e9. France", 
                "last_name": "Sidney Chocron, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universit\u00e9 de Franche-Comt\u00e9. France", 
                "last_name": "Andrea Perrotti, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universit\u00e9 de Franche-Comt\u00e9. France", 
                "last_name": "Simon Rinckenbach, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universit\u00e9 de Franche-Comt\u00e9. France", 
                "last_name": "Siamak Davani, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Health Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients are followed for 2 years", 
            "measure": "Circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood concentration", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "reference": {
            "PMID": "21481600", 
            "citation": "Parietti E, Pallandre JR, Deschaseaux F, Aup\u00e8cle B, Durst C, Kantelip JP, Chocron S, Davani S. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1\u03b1 are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg. 2011 Jul;40(1):e6-12. doi: 10.1016/j.ejcts.2011.02.065. Epub 2011 Apr 9."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918982"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hopital Jean Minjoz", 
            "investigator_full_name": "Prof. Sidney Chocron", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hopital Jean Minjoz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Jean Minjoz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}